Indivior Proposes New Corporate Structure To Achieve U.S. Domiciliation

Reuters
2025.10.01 13:56
portai
I'm PortAI, I can summarize articles.

Indivior PLC has proposed a new corporate structure to change its domicile from the U.K. to the U.S. Shareholders will receive one share of Indivior Pharmaceuticals, Inc. (IPI) for each PLC share, with no additional equity raised. Indivior PLC will become a wholly owned subsidiary of IPI, which will be listed on NASDAQ under the symbol INDV. The scheme is expected to be effective by January 2026.

Oct 1 (Reuters) - Indivior PLC (2IVB.D) :

  • INDIVIOR PROPOSES NEW CORPORATE STRUCTURE TO ACHIEVE U.S. DOMICILIATION
  • INDIVIOR PLC - TO CHANGE DOMICILE FROM U.K. TO U.S.
  • INDIVIOR PLC - SHAREHOLDERS TO RECEIVE ONE IPI SHARE PER PLC SHARE
  • INDIVIOR PLC: NO ADDITIONAL EQUITY WILL BE RAISED BY IPI AS PART OF TRANSACTION
  • INDIVIOR PLC: INDIVIOR PLC WILL BECOME A DIRECT WHOLLY OWNED SUBSIDIARY OF IPI
  • INDIVIOR: WILL ESTABLISH NEW U.S. PARENT CO, INDIVIOR PHARMACEUTICALS, ABOVE EXISTING UK PARENT CO
  • INDIVIOR PLC - EXPECTS SCHEME EFFECTIVE JANUARY 2026, PLC SHARES EXCHANGED FOR IPI
  • INDIVIOR: IPI’S STOCK WILL BE LISTED ON NASDAQ AND WILL CONTINUE TO TRADE UNDER SYMBOL INDV Source text: Further company coverage: (2IVB.D)
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.